11 citations · 23 across the 6 of their papers we have counts for
Showing 2022Show all
2 papers · 1 filter
stat.ME2022★ 1 cited
Towards Optimal Use of Surrogate Markers to Improve Power
Xuan Wang, Layla Parast, Lu Tian +1
Motivated by increasing pressure for decision makers to shorten the time required to evaluate the efficacy of a treatment such that treatments deemed safe and effective can be made…
stat.ME2022★ 1 cited
Using a Surrogate with Heterogeneous Utility to Test for a Treatment Effect
Layla Parast, Tianxi Cai, Lu Tian
The primary benefit of identifying a valid surrogate marker is the ability to use it in a future trial to test for a treatment effect with shorter follow-up time or less cost. Howe…